Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
Giving entire course of radiation treatment in less than a second is feasible
Cancer patients may one day be able to get their entire course of radiation therapy…
Plant-derived SVC112 hits cancer stem cells, leaves healthy cells alone
The red, tube-shaped flowers of the firecracker bush (Bouvardia ternifolia), native to Mexico and the…
Researchers surprised by high levels of alcohol consumption among cancer survivors
New research in the January 2020 issue of JNCCN – Journal of the National Comprehensive Cancer…
The changing face of esophageal cancer: How to avoid the knife?
Professor Rebecca K.S. Wong for oncologynews.com.au. For patients presenting with localized esophageal cancer, conventionally the first treatment decision is often…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.